Safest Dose Of GLP (NEXT-LEVEL Appetite Suppression) Insulin Sensitivity, Fat Loss Deep-Dive
Vigorous Steve — Safest Dose Of GLP (NEXT-LEVEL Appetite Suppression) Insulin Sensitivity, Fat Loss Deep-Dive
Channel: VigorousSteve · Our label: Fitness / PED educator · Source: youtube.com/watch?v=T313me9pKw4
What this video covers
And that’s because there’s a new GLP-1 receptor agonist in town. Everybody, literally everybody, including all of the GLP-1 adverse blue collar hardcore bodybuilders with 100% control over their appetites are running it right now. Before we get into the retrotride deep dive, please understand that all studies performed on retrotutite were published from September 2022 onwards. And it means none of them are available as full publications through sciencehub.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- For this deep dive, I didn’t purchase a single study as the total value of studies locked behind the payw wall was $1645, give or take.
- Now unfortunately uh the results of clinical trials performed on healthy individuals are nowhere to be found.
- It will be a while before this is FDA approved and for now we have to rely on the Chinese generic peptide websites to get our retroites in through the mail.
- So by the time retroite hits the market and it is approved as a medication, then the total sample size of people participating in clinical trials was over 20,000 people.
- And regarding the safety profile, retroite seems to be consistent and comparable with other incretinant based medications whether those are solo GLP-1 receptor agonist or combination medications GLP1 and GIP receptor agonists.
- Retutide agonizes the glucagon like peptide 1 receptor with 2.5fold less so that’s 0.4 times less potency compared to endogenously produced glucagon like peptide 1 stemming from an invitro study.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.